Trials / Unknown
UnknownNCT00265694
Random Trial for Elderly Patients With NSCLC
A Randomized Phase III Trial of Vinorelbine Versus Gemcitabine and Carboplatin for Elderly Patients With Advanced Non-Small Cell Lung Cancer
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Inje University · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
1. Recently a radomized trial of vinorelbine versus best supportive care in patients at 70 years of age or older demonstrated a definite improvement in overall survival rate and quality of life with chemotherapy. 2. The role of combination therapy containing the platinum compound, which is the standard therapy for the young patients is still vague. 3. Gemcitabine and carboplatin have favorable toxicity profile.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | vinorelbine, gemcitabine and carboplatin |
Timeline
- First posted
- 2005-12-15
- Last updated
- 2005-12-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00265694. Inclusion in this directory is not an endorsement.